About company

TexRAD is develops a medical imaging software application that assists in clinical decision-making by predicting the risk of disease and assessing the prognosis for cancer patients. It offers TexRAD, an imaging risk stratification tool that analyses clinical diagnostic images, detects and measures tumor complexity from these images, and reveals information from medical images. The company’s imaging risk stratification tool is also used as an imaging biomarker for prognosis and treatment response in cancer patients; and quantifies heterogeneity within medical images of tumours by assessing the distribution of grey-levels, coarseness, and regularity within a lesion.

Unknown
Unknown
Not verified company